Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from Evogene ( (EVGN) ) is now available.
Evogene Ltd., an Israeli company, has announced a Special General Meeting of Shareholders scheduled for February 5, 2025. The primary agenda for the meeting is to approve the grant of options for purchasing 160,000 of the company’s ordinary shares to its President and CEO, Ofer Haviv. The approval requires a majority vote from non-controlling shareholders without any conflict of interest. The Board of Directors unanimously supports this proposal, and shareholders are encouraged to vote in person or remotely.
More about Evogene
YTD Price Performance: -80.36%
Average Trading Volume: 297,816
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.85M
For a thorough assessment of EVGN stock, go to TipRanks’ Stock Analysis page.
